FGFBP3 and glioblastoma: FGFBP3, VAX2, and SHD were all protective prognostic factors for overall survival (OS) and disease free survival (DFS) (log rank p < 0.05, p(HR) < 0.05, Figures 5(a), 5(c), and 5(e)), while no significant impact was found in GBM (log rank p > 0.05, p(HR) > 0.05, Figures 5(b), 5(d), and 5(f)).